AU Stock MarketDetailed Quotes

Clarity Pharmaceuticals Ltd (CU6)

Watchlist
  • 2.900
  • +0.070+2.47%
20min DelayMarket Closed May 1 16:00 AET
1.08BMarket Cap-14.43P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Clarity Pharmaceuticals Ltd (CU6) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2025
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
Operating cash flow (direct method)
Cash income from operating activities
12.00%11.15M
47.94%9.95M
106.17%6.73M
3.26M
Other cash income from operating activities
12.00%11.15M
47.94%9.95M
106.17%6.73M
--3.26M
Cash paid
-27.78%-70.54M
-54.62%-55.2M
-114.63%-35.7M
-16.63M
Payments to suppliers for goods and services
-27.78%-70.54M
-54.62%-55.2M
-114.63%-35.7M
---16.63M
Direct interest received
155.09%5.35M
32.62%2.1M
1,989.39%1.58M
--75.62K
Direct tax refund paid
-788.11%-719.25K
21.52%-80.99K
-485.30%-103.2K
---17.63K
Operating cash flow
-26.67%-54.77M
-57.23%-43.24M
-106.55%-27.5M
---13.31M
Investing cash flow
Cash flow from continuing investing activities
194.00%51.99M
-1,855.24%-55.31M
111.80%3.15M
-26.71M
Net PPE purchase and sale
63.74%-182.74K
-982.44%-504.01K
78.16%-46.56K
---213.15K
Net investment purchase and sale
195.19%52.17M
-1,813.92%-54.8M
112.07%3.2M
---26.5M
Cash from discontinued investing activities
Investing cash flow
194.00%51.99M
-1,855.24%-55.31M
111.80%3.15M
---26.71M
Financing cash flow
Cash flow from continuing financing activities
-98.08%2.21M
49,649.97%115.21M
-99.73%231.58K
86.93M
Net common stock issuance
-98.08%2.21M
67,428.20%115.19M
-99.80%170.59K
--86.8M
Net other financing activities
----
-67.21%20K
-53.79%61K
--132K
Cash from discontinued financing activities
Financing cash flow
-98.08%2.21M
49,649.97%115.21M
-99.73%231.58K
--86.93M
Net cash flow
Beginning cash position
53.46%47.9M
-43.59%31.21M
555.72%55.34M
--8.44M
Current changes in cash
-103.42%-570.32K
169.11%16.67M
-151.42%-24.12M
--46.9M
Effect of exchange rate changes
1,709.32%353.81K
432.85%19.56K
-85.92%-5.88K
---3.16K
End cash Position
-0.45%47.68M
53.46%47.9M
-43.59%31.21M
--55.34M
Free cash from
-25.63%-54.95M
-58.79%-43.74M
-103.64%-27.55M
---13.53M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2025(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022
Operating cash flow (direct method)
Cash income from operating activities 12.00%11.15M47.94%9.95M106.17%6.73M3.26M
Other cash income from operating activities 12.00%11.15M47.94%9.95M106.17%6.73M--3.26M
Cash paid -27.78%-70.54M-54.62%-55.2M-114.63%-35.7M-16.63M
Payments to suppliers for goods and services -27.78%-70.54M-54.62%-55.2M-114.63%-35.7M---16.63M
Direct interest received 155.09%5.35M32.62%2.1M1,989.39%1.58M--75.62K
Direct tax refund paid -788.11%-719.25K21.52%-80.99K-485.30%-103.2K---17.63K
Operating cash flow -26.67%-54.77M-57.23%-43.24M-106.55%-27.5M---13.31M
Investing cash flow
Cash flow from continuing investing activities 194.00%51.99M-1,855.24%-55.31M111.80%3.15M-26.71M
Net PPE purchase and sale 63.74%-182.74K-982.44%-504.01K78.16%-46.56K---213.15K
Net investment purchase and sale 195.19%52.17M-1,813.92%-54.8M112.07%3.2M---26.5M
Cash from discontinued investing activities
Investing cash flow 194.00%51.99M-1,855.24%-55.31M111.80%3.15M---26.71M
Financing cash flow
Cash flow from continuing financing activities -98.08%2.21M49,649.97%115.21M-99.73%231.58K86.93M
Net common stock issuance -98.08%2.21M67,428.20%115.19M-99.80%170.59K--86.8M
Net other financing activities -----67.21%20K-53.79%61K--132K
Cash from discontinued financing activities
Financing cash flow -98.08%2.21M49,649.97%115.21M-99.73%231.58K--86.93M
Net cash flow
Beginning cash position 53.46%47.9M-43.59%31.21M555.72%55.34M--8.44M
Current changes in cash -103.42%-570.32K169.11%16.67M-151.42%-24.12M--46.9M
Effect of exchange rate changes 1,709.32%353.81K432.85%19.56K-85.92%-5.88K---3.16K
End cash Position -0.45%47.68M53.46%47.9M-43.59%31.21M--55.34M
Free cash from -25.63%-54.95M-58.79%-43.74M-103.64%-27.55M---13.53M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -